Search Result "E255V"
Molecular Dynamic Studies Unveil Potential Mechanisms of Resistance to Imatinib in BCR-ABL Mutants
Ebook: Topics in Anti-Cancer Research
Volume: 3 Year: 2014
Author(s): Tai-Sung Lee,Steven J. Potts,Maher Albitar
Doi: 10.2174/9781608059089114030011
Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy
Journal: Current Drug Metabolism
Volume: 18 Issue: 3 Year: 2017 Page: 199-206
Author(s): Ruiqing Wang,Chaoqin Zhong,Chen Zhang,Mingqiang Hua,Daoxin Ma
Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 164-173
Author(s): Tai-Sung Lee, Steven J. Potts, Maher Albitar
Allosteric Inhibitors of Bcr-Abl: Towards Novel Myristate-Pocket Binders
Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 5 Year: 2013 Page: 477-487
Author(s): Marco Radi,Silvia Schenone,Maurizio Botta
Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL
Journal: Current Drug Targets
Volume: 10 Issue: 6 Year: 2009 Page: 530-536
Author(s): Massimo Breccia, Giuliana Alimena
In Silico Identification and Analysis of Drug Resistant Mutants of ABL Tyrosine Kinase Based on Detrimental Missense Mutations
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 3 Year: 2011 Page: 396-404
Author(s): R. Rajasekaran, C. George Priya Doss, G. Arun Prasad, Rao Sethumadhavan
Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 4 Year: 2012 Page: 391-401
Author(s): M. Breccia,G. Alimena
Tyrosine Kinase Inhibitor Resistance and Epigenetic Regulation of SHP1 Phosphatase Expression in Chronic Myeloid Leukemia
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 12 Issue: 4 Year: 2014 Page: 240-249
Author(s): Molly Steele,Amy Liu,Kate Bernhardt,Jennifer McCall,Brett Mahon,Lela Buckingham
Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Shinya Kimura
Doi: 10.2174/978160805161811001010116
Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 8 Year: 2009 Page: 853-863
Author(s): Manlio Tolomeo, Francesco Dieli, Nicola Gebbia, Daniele Simoni